A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

NCT01294202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumor (GIST)

Interventions

DRUG: AT13387 and Imatinib

Sponsor

Astex Pharmaceuticals, Inc.